Abstract
MicroRNA (miR-221/222) is frequently overexpressed in many cancers and is associated with poor prognosis. However, the role of miR-221/222 in retinoblastoma (RB) remains unclear. This study aimed to detect the clinical significance of miR-221/222 in RB patients and explore its role in RB cells in vitro. Expression of miR-221/222 was assessed in fresh RB tissue collected from 64 eyes and normal retinal tissues from 18 unrelated donor cadaver eyes by quantitative real time RT-PCR analysis (qRT-PCR), and correlated with the histopathological findings. Human RB Y79 cells were transfected with miR-221/222 precursors or inhibitors to overexpress or downregulate miR-221/222 expression, respectively, using Lipofectamine 2000 reagent. The biological effects of miR-221/222 were then assessed by cell viability assays, colony formation assays, apoptosis detection assays, Matrigel® invasion assays, and wound-healing assays. Higher miR-221/222 expression was detected in RB tissues compared to that of the normal retinal tissues (p< 0.001). Higher miR-221/222 expression was correlated with invasion in patients with RB. Targeting of miR-221/222 induced apoptosis and inhibited Y79 cell proliferation, migration, and invasion in vitro. However, ov...Continue Reading
References
Jun 16, 2007·The Journal of Biological Chemistry·Silvia GalardiMaria Giulia Farace
Dec 11, 2007·Trends in Pharmacological Sciences·Angelika KuehbacherStefanie Dimmeler
Feb 5, 2008·Oncogene·M GarofaloG Condorelli
Apr 17, 2008·Cancer Research·Ricardo MedinaGary S Stein
Sep 16, 2008·The Journal of Biological Chemistry·Jian-Jun ZhaoJin Q Cheng
Dec 25, 2008·PloS One·Neri MercatelliSilvia Anna Ciafrè
Mar 3, 2009·Blood·Andrea J O'HaraDirk P Dittmer
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura GramantieriMassimo Negrini
Dec 2, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Richard HummelJoerg Haier
Jun 15, 2010·Journal of Cardiovascular Translational Research·Zifang Song, Guohong Li
Oct 1, 2010·Journal of Gastroenterology and Hepatology·Xing-xiang PuTong-yu Lin
Oct 12, 2010·Methods in Molecular Biology·Julia Winter, Sven Diederichs
Jan 29, 2011·Journal of Dermatological Science·Hisashi KanemaruHironobu Ihn
Apr 15, 2011·Molecular Cancer·Ewan A GibbWan L Lam
Nov 1, 2011·Experimental Gerontology·Catarina RippeDouglas R Seals
Jan 13, 2012·Nature·Jinghui ZhangMichael A Dyer
May 23, 2012·The Journal of International Medical Research·K LiuJ Li
Oct 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria T Di MartinoPierfrancesco Tassone
Sep 13, 2013·Medical Oncology·ChongLek LeeDeliang Fu
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Sep 17, 2014·Nature Reviews. Clinical Oncology·Alessia Errico
Apr 18, 2015·Oncotarget·Qinhong XuZheng Wang
Jul 30, 2015·BioMed Research International·Dmitry A ChistiakovYuri V Bobryshev
Citations
Aug 23, 2019·Wiley Interdisciplinary Reviews. RNA·Shama Prasada KabekkoduKapaettu Satyamoorthy
Jan 8, 2020·Cells·Lisa Linck-PaulusPeter Dietrich
Aug 28, 2019·Oncology Letters·Ke XuBin Wang
Oct 24, 2018·Journal of Cancer Research and Clinical Oncology·Lara Elis Alberici DelsinMaria Sol Brassesco
Nov 2, 2019·Journal of Cellular Biochemistry·Fengge LiuYan Liang
Jan 14, 2020·Journal of Oncology·Qian SongXin Cao
Jun 16, 2021·Genes & Genomics·Manhai GaoQiang Cai
Jul 3, 2021·International Journal of Molecular Sciences·Adriana FodorAngela Cozma
Oct 30, 2021·Cutaneous and Ocular Toxicology·Lei LiuQiuyun Sun
Oct 3, 2019·Oncology Research and Treatment·Lianyun WangYing Hua
Aug 14, 2021·Anti-cancer Drugs·Hui ZhangBo Ye